Molecular Formula | C16H20BrNO3 |
Molar Mass | 354.24 |
Density | 1.361±0.06 g/cm3(Predicted) |
Boling Point | 453.1±45.0 °C(Predicted) |
pKa | -2.91±0.60(Predicted) |
Introduction | (3R,4S)-3-(2-bromoacetyl) benzyl 4-ethyl-1-pyrrolidinecarboxylate is a key intermediate for upatinib. In early 2018, Upadacitinib (ABT-494), a once-daily selective JAK1 inhibitor for the treatment of moderate to severe atopic dermatitis in adults, obtained FDA breakthrough therapy approval. |
Use | (3R,4S)-3-(2-bromoacetyl) 4-ethyl-1-pyrrolidine carboxylic acid benzyl ester is a carboxylic acid ester-based organic compound that can be used as a key intermediate for upatinib. |